Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Dopchie · SciRah

Researcher profile · Semantic Scholar

C. Dopchie

Share profile

C. Dopchie — researcher profile on SciRah

h-index: 5
Works: 18
Citations: 189

Most-cited papers

Prospective randomized study comparing docetaxel, estramustine, and prednisone with docetaxel and prednisone in metastatic hormone-refractory prostate cancer.
J. Machiels, F. Mazzeo, M. Clausse, B. Filleul +12 more
2008Journal of Clinical Oncology90 citations Open access
Semantic Scholar
Abiraterone acetate plus prednisone for the Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC) without prior use of chemotherapy: report from a large, international, real-world retrospective cohort study
Martin Boegemann, S. Khaksar, G. Bera, A. Birtle +13 more
2019BMC Cancer42 citations Open access
Semantic Scholar
A European, Observational, Prospective Trial of Trabectedin Plus Pegylated Liposomal Doxorubicin in Patients with Platinum‐Sensitive Ovarian Cancer
S. Pignata, G. Scambia, A. Villanucci, E. Naglieri +9 more
2020The Oncologist17 citations Open access
Semantic Scholar
Five-Year Analysis of the FNCLCC-PACS04 Trial: FEC100 vs ED75 for the Adjuvant Treatment of Node Positive Breast Cancer.
H. Roche, D. Allouache, G. Romieu, H. Bourgeois +16 more
200913 citations
Semantic Scholar
Weekly carboplatin plus neoadjuvant anthracycline-taxane-based regimen in early triple-negative breast cancer: a prospective phase II trial by the Breast Cancer Task Force of the Belgian Society of Medical Oncology (BSMO)
C. Fontaine, V. Renard, H. V. D. van den Bulk, P. Vuylsteke +8 more
2019Breast Cancer Research and Treatment12 citations Open access
Semantic Scholar
Phase III trial of docetaxel (D), estramustine (E), and prednisone versus docetaxel plus prednisone in patients with metastatic hormone-refractory prostate cancer (HRPC)
J. Machiels, F. Mazzeo, M. Clausse, B. Filleul +6 more
20074 citations
Semantic Scholar
Efficacy and Safety of Lanreotide Autogel in the Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction: A Prospective Phase II Study.
L. Duck, G. Demolin, L. D'Hondt, C. Dopchie +10 more
2021Clinical Therapeutics3 citations Open access
Semantic Scholar
[Gallbladder metastasis from breast carcinoma: a new case report].
B. Essola, P. Malvaux, J. Landenne, S. Kargar +4 more
2012Revue Medicale de Bruxelles3 citations
Semantic Scholar
Abiraterone acetate plus prednisone for the Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC) without prior use of chemotherapy: report from a large, international, real-world retrospective cohort study
Martin Boegemann, S. Khaksar, G. Bera, A. Birtle +13 more
2019BMC Cancer2 citations Open access
Semantic Scholar
Real-world treatment with abiraterone acetate in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC).
M. Boegemann, M. Hatzinger, D. Hercher, G. Matus +11 more
20172 citations
Semantic Scholar
The Doctor Turned into an Instrument
C. Dopchie
20211 citations Open access
Semantic Scholar
Efficacy and safety of lanreotide 120 mg in the treatment of clinical symptoms associated with inoperable malignant intestinal obstruction (IMIO): Results from a phase II multicenter study.
L. Duck, G. Demolin, L. D'Hondt, C. Dopchie +9 more
2019Journal of Clinical Oncology1 citations
Semantic Scholar
Heterozygote Germline Mutations in Homologous Recombination Core Genes Can Predict for Pathologic Complete Response in Early Triple Negative Breast Cancer
C. Fontaine, S. de Brakeleer, E. Teugels, V. Renard +10 more
2023Journal of Biotechnology and Biomedicine0 citations Open access
Semantic Scholar
Abstract P1-10-05: Evaluation of germline whole exome sequencing of early breast cancer patients with triple negative breast cancer (TNBC) included in a prospective study of neoadjuvant chemotherapy (NAC) with epirubicin and cyclophosphamide (EC) and carboplatin-paclitaxel (PC) (BSMO 2014-01)
C. Fontaine, V. Renard, H. V. D. van den Bulck, P. Vuylsteke +8 more
2020Poster Session Abstracts0 citations
Semantic Scholar
Abstract P6-15-09: Final results of weekly (w) neoadjuvant carboplatin (Cp) added to paclitaxel (P) followed by epirubicin (E) and cyclophosphamide (C) in triple negative breast cancer (TNBC) patients (pts): A BSMO breast cancer task force phase II study
C. Fontaine, N. Cappoen, V. Renard, H. V. D. van den Bulck +7 more
20180 citations
Semantic Scholar
Abstract P5-16-06: Neoadjuvant weekly carboplatin and paclitaxel followed by dose dense epirubicin and cyclophosphamide in triple negative breast cancer patients: A single arm phase II study from the Belgian Society of Medical Oncology
C. Fontaine, N. Cappoen, V. Renard, P. Vuylsteke +9 more
20170 citations
Semantic Scholar
A RETROSPECTIVE SURVEY OF SYSTEMIC ANTICANCER THERAPY IN WOMEN WITH METASTATIC BREAST CANCER (MBC) IN BELGIUM
C. Fontaine, J. Janssens, C. Dopchie, C. Nouwynck
20100 citations
Semantic Scholar
Abstract P6-11-08: A Comparison of Chemotherapeutic Treatment Practice in Metastatic Breast Cancer (MBC) in Belgium (BE) and The Netherlands (NL)
E. de Jongh, D. van Brummelen, L. V. van Warmerdam, C. Fontaine +4 more
20100 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Glorieux×5
Invite
P. Glorieux — researcher profile on SciRah
L. D'Hondt×4
Invite
L. D'Hondt — researcher profile on SciRah
C. Fontaine×4
Invite
C. Fontaine — researcher profile on SciRah
V. Renard×4
Invite
V. Renard — researcher profile on SciRah

×4

Invite

P. Vuylsteke — researcher profile on SciRah

Invite

L. Decoster — researcher profile on SciRah

J. De Grève×4

Invite

J. De Grève — researcher profile on SciRah

Invite

A. Awada — researcher profile on SciRah

Invite

H. Wildiers — researcher profile on SciRah

H. V. D. van den Bulck×4

Invite

H. V. D. van den Bulck — researcher profile on SciRah

Invite

L. Duck — researcher profile on SciRah

Invite

A. Birtle — researcher profile on SciRah